Valeo Pharma Inc (CSE:VPH) (OTCQB:VPHI) (FRA:VP2), a Canadian specialty pharmaceutical company, announced Tuesday that it has commenced shipping online orders of its unique flavonoid formulation.
Hesperco capsules contain a powerful antioxidant that provides support for the immune system, the company said in a statement.
“Valeo is pleased to announce that we have started fulfilling online orders of Hesperco,” said CEO Steve Saviuk. “We strongly believe that the immune system support provided by Hesperco capsules is very important in these challenging times.”
READ: Valeo Pharma wins Health Canada natural product licence for its immune support Hesperco capsules
He added that Valeo expects the Hesperco capsules will be available in major health care retailers across the country in early November.
Valeo entered into a collaboration and licensing agreement with Ingenew Pharma Inc in April 2020 for the development, manufacture, and commercialization of Hesperco. Ingenew is responsible for providing clinical and scientific data to support the market positioning, commercial and communication campaigns for Hesperco.
Kirkland, Quebec-based Valeo commercializes innovative prescription and over-the-counter products in Canada, with a focus on neurodegenerative diseases, oncology, and hospital specialty products.
Contact the author: [email protected]
Follow him on Twitter @PatrickMGraham